Ascending to new heights for novel therapeutics for eosinophilic esophagitis.

Hirano, Ikuo; Dellon, Evan S; Falk, Gary W; Gonsalves, Nirmala P; Furuta, Glenn T; Bredenoord, Albert J (2024). Ascending to new heights for novel therapeutics for eosinophilic esophagitis. Gastroenterology, 166(1), pp. 1-10. Elsevier 10.1053/j.gastro.2023.09.004

[img] Text
1-s2.0-S001650852304979X-main.pdf - Accepted Version
Restricted to registered users only until 10 September 2024.
Available under License Publisher holds Copyright.

Download (733kB) | Request a copy
[img] Text
Hirano_Gastroenterology_2024.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (679kB) | Request a copy

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0016-5085

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

12 Sep 2023 10:04

Last Modified:

15 Feb 2024 01:42

Publisher DOI:

10.1053/j.gastro.2023.09.004

PubMed ID:

37690772

Additional Information:

Ekaterina Safroneeva participated in the 'Assessment of Clinical endpoints in Eosinophilic esophagitis for Novel Therapeutics (ASCENT) working group'.

Uncontrolled Keywords:

Eosinophilic esophagitis clinical trial design eosinophil esophagitis

BORIS DOI:

10.48350/186211

URI:

https://boris.unibe.ch/id/eprint/186211

Actions (login required)

Edit item Edit item
Provide Feedback